216 related articles for article (PubMed ID: 33221956)
21. C11orf95-RELA fusion drives aberrant gene expression through the unique epigenetic regulation for ependymoma formation.
Ozawa T; Kaneko S; Szulzewsky F; Qiao Z; Takadera M; Narita Y; Kondo T; Holland EC; Hamamoto R; Ichimura K
Acta Neuropathol Commun; 2021 Mar; 9(1):36. PubMed ID: 33685520
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional profiling of paediatric ependymomas identifies prognostically significant groups.
Łastowska M; Matyja E; Sobocińska A; Wojtaś B; Niemira M; Szałkowska A; Krętowski A; Karkucińska-Więckowska A; Kaleta M; Ejmont M; Tarasińska M; Perek-Polnik M; Dembowska-Bagińska B; Pronicki M; Grajkowska W; Trubicka J
J Pathol Clin Res; 2021 Nov; 7(6):565-576. PubMed ID: 34314101
[TBL] [Abstract][Full Text] [Related]
23. Infratentorial C11orf95-fused gliomas share histologic, immunophenotypic, and molecular characteristics of supratentorial RELA-fused ependymoma.
Keenan C; Graham RT; Harreld JH; Lucas JT; Finkelstein D; Wheeler D; Li X; Dalton J; Upadhyaya SA; Raimondi SC; Boop FA; DeCuypere M; Zhang J; Vinitsky A; Wang L; Chiang J
Acta Neuropathol; 2020 Dec; 140(6):963-965. PubMed ID: 33099686
[No Abstract] [Full Text] [Related]
24. Supratentorial ependymomas of childhood carry C11orf95-RELA fusions leading to pathological activation of the NF-κB signaling pathway.
Pietsch T; Wohlers I; Goschzik T; Dreschmann V; Denkhaus D; Dörner E; Rahmann S; Klein-Hitpass L
Acta Neuropathol; 2014 Apr; 127(4):609-11. PubMed ID: 24562983
[No Abstract] [Full Text] [Related]
25. Ependymoma-like tumor with mesenchymal differentiation (ELTMD) with ZFTA:NCOA1 fusion: A diagnostic challenge.
Dorwal P; White C; Goh AF; Kumar A; McEniery J; Walker R; Robertson T
Neuropathology; 2024 Jun; 44(3):216-221. PubMed ID: 37931917
[TBL] [Abstract][Full Text] [Related]
26. Childhood supratentorial ependymomas with YAP1-MAMLD1 fusion: an entity with characteristic clinical, radiological, cytogenetic and histopathological features.
Andreiuolo F; Varlet P; Tauziède-Espariat A; Jünger ST; Dörner E; Dreschmann V; Kuchelmeister K; Waha A; Haberler C; Slavc I; Corbacioglu S; Riemenschneider MJ; Leipold A; Rüdiger T; Körholz D; Acker T; Russo A; Faber J; Sommer C; Armbrust S; Rose M; Erdlenbruch B; Hans VH; Bernbeck B; Schneider D; Lorenzen J; Ebinger M; Handgretinger R; Neumann M; van Buiren M; Prinz M; Roganovic J; Jakovcevic A; Park SH; Grill J; Puget S; Messing-Jünger M; Reinhard H; Bergmann M; Hattingen E; Pietsch T
Brain Pathol; 2019 Mar; 29(2):205-216. PubMed ID: 30246434
[TBL] [Abstract][Full Text] [Related]
27. Molecular genetics of ependymomas and pediatric diffuse gliomas: a short review.
Nobusawa S; Hirato J; Yokoo H
Brain Tumor Pathol; 2014 Oct; 31(4):229-33. PubMed ID: 25182241
[TBL] [Abstract][Full Text] [Related]
28. Pediatric Supratentorial Ependymoma: Surgical, Clinical, and Molecular Analysis.
Lillard JC; Venable GT; Khan NR; Tatevossian RG; Dalton J; Vaughn BN; Klimo P
Neurosurgery; 2019 Jul; 85(1):41-49. PubMed ID: 29917116
[TBL] [Abstract][Full Text] [Related]
29. ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma.
Arabzade A; Zhao Y; Varadharajan S; Chen HC; Jessa S; Rivas B; Stuckert AJ; Solis M; Kardian A; Tlais D; Golbourn BJ; Stanton AJ; Chan YS; Olson C; Karlin KL; Kong K; Kupp R; Hu B; Injac SG; Ngo M; Wang PR; De León LA; Sahm F; Kawauchi D; Pfister SM; Lin CY; Hodges HC; Singh I; Westbrook TF; Chintagumpala MM; Blaney SM; Parsons DW; Pajtler KW; Agnihotri S; Gilbertson RJ; Yi J; Jabado N; Kleinman CL; Bertrand KC; Deneen B; Mack SC
Cancer Discov; 2021 Sep; 11(9):2200-2215. PubMed ID: 33741710
[TBL] [Abstract][Full Text] [Related]
30. Specific expression of PD-L1 in RELA-fusion supratentorial ependymoma: Implications for PD-1-targeted therapy.
Witt DA; Donson AM; Amani V; Moreira DC; Sanford B; Hoffman LM; Handler MH; Levy JMM; Jones KL; Nellan A; Foreman NK; Griesinger AM
Pediatr Blood Cancer; 2018 May; 65(5):e26960. PubMed ID: 29350470
[TBL] [Abstract][Full Text] [Related]
31. Atypical Teratoid/Rhabdoid Tumor (AT/RT) Arising From Ependymoma: A Type of AT/RT Secondarily Developing From Other Primary Central Nervous System Tumors.
Nobusawa S; Hirato J; Sugai T; Okura N; Yamazaki T; Yamada S; Ikota H; Nakazato Y; Yokoo H
J Neuropathol Exp Neurol; 2016 Feb; 75(2):167-74. PubMed ID: 26769252
[TBL] [Abstract][Full Text] [Related]
32. The Multifaceted Appearance of Supratentorial Ependymoma with ZFTA-MAML2 Fusion.
Oon ML; Hendriansyah L; Pratiseyo PD; Wahjoepramono E; Goh JY; Kuick CH; Chang KT; Perry A; Tan CL
Free Neuropathol; 2021 Jan; 2():. PubMed ID: 37284641
[TBL] [Abstract][Full Text] [Related]
33. Extra-Ventricular C11orf95-RELA Fusion Positive Anaplastic Ependymoma with Divergent Histological and Immunohistochemical Features: Report of a Rare Case.
Purkait S; Nayak M; Patnaik A; Patra S; Malgulwar PB
Neurol India; 2021; 69(4):1060-1062. PubMed ID: 34507448
[No Abstract] [Full Text] [Related]
34. C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma.
Parker M; Mohankumar KM; Punchihewa C; Weinlich R; Dalton JD; Li Y; Lee R; Tatevossian RG; Phoenix TN; Thiruvenkatam R; White E; Tang B; Orisme W; Gupta K; Rusch M; Chen X; Li Y; Nagahawhatte P; Hedlund E; Finkelstein D; Wu G; Shurtleff S; Easton J; Boggs K; Yergeau D; Vadodaria B; Mulder HL; Becksfort J; Gupta P; Huether R; Ma J; Song G; Gajjar A; Merchant T; Boop F; Smith AA; Ding L; Lu C; Ochoa K; Zhao D; Fulton RS; Fulton LL; Mardis ER; Wilson RK; Downing JR; Green DR; Zhang J; Ellison DW; Gilbertson RJ
Nature; 2014 Feb; 506(7489):451-5. PubMed ID: 24553141
[TBL] [Abstract][Full Text] [Related]
35. Supratentorial cortical ependymoma: A systematic literature review and case illustration.
Cuoco JA; Strohman AC; Stopa BM; Stump MS; Entwistle JJ; Witcher MR; Olasunkanmi AL
Rare Tumors; 2022; 14():20363613221112432. PubMed ID: 35836750
[TBL] [Abstract][Full Text] [Related]
36. Cortically based cystic supratentorial RELA fusion-positive ependymoma: a case report with unusual presentation and appearance and review of literature.
Sallam YT; Zhang Q; Pandey SK
Radiol Case Rep; 2020 Dec; 15(12):2495-2499. PubMed ID: 33033550
[TBL] [Abstract][Full Text] [Related]
37. Clinical, radiological, and histological features and treatment outcomes of supratentorial extraventricular ependymoma: 14 cases from a single center.
Sun S; Wang J; Zhu M; Beejadhursing R; Gao P; Zhang X; Jiao L; Jiang W; Ke C; Shu K
J Neurosurg; 2018 May; 128(5):1396-1402. PubMed ID: 28686116
[TBL] [Abstract][Full Text] [Related]
38. RELA Fusion in Supratentorial Extraventricular Ependymomas: A Morphologic, Immunohistochemical, and Molecular Study of 43 Cases.
Wang L; Liu L; Li H; Wang P; Hu Z; Wei Y; Zhang M; Wen W; Li Z; Liu L; Zhao L; Lu D; Teng L
Am J Surg Pathol; 2019 Dec; 43(12):1674-1681. PubMed ID: 31393268
[TBL] [Abstract][Full Text] [Related]
39. A novel YAP1-MAML2 fusion in an adult supra-tentorial ependymoma, YAP1-fused.
Tauziède-Espariat A; Siegfried A; Nicaise Y; Figarella-Branger D; Appay R; Senova S; Bochaton D; Hasty L; Martin A; Chrétien F; Métais A; Varlet P; Uro-Coste E;
Brain Tumor Pathol; 2022 Oct; 39(4):240-242. PubMed ID: 35598201
[No Abstract] [Full Text] [Related]
40. Cortical ependymoma: an unusual epileptogenic lesion.
Van Gompel JJ; Koeller KK; Meyer FB; Marsh WR; Burger PC; Roncaroli F; Worrell GA; Giannini C
J Neurosurg; 2011 Apr; 114(4):1187-94. PubMed ID: 21235315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
